Health Robotics, a supplier of life-critical intra-venous medication robots, has served notice to McKesson regarding termination of CytoCare distribution and services contract in North America.

Health Robotics claims that CytoCare guarantees a dosage accuracy within 95%+. The therapeutic window of medications can be optimally used, providing your patients with the most effective treatment.

Additionally, Health Robotics has also informed McKesson for the termination of its non exclusive distribution agreement for i.v.STATION and i.v.SOFT within a subset of McKesson Automation’s customers.